Home›Companies›Healthcare›Perfusio

Perfusio Corp.

Updated Oct 27, 2026·Latest SEC filing Dec 10, 2024·Suggest an edit

About Perfusio

Perfusio is a private company based in Greenville, North Carolina. It has reported $16,358,881 raised in six offerings on Form D since November 2015.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Nov 13, 2024Dec 10, 2024$2,195,656of $3.9M target36$60,990EquityRule 506(b)Form D ↗
Jul 29, 2022Jan 31, 2023$1,597,580of $2.6M target26$61,445OptionsRule 506(b)Form D ↗
Aug 7, 2020Aug 19, 2020amended Sep 15, 2021$4,962,037of $8.5M target16$310KEquityRule 506(b)Form D/A ↗1 earlier filing
Mar 8, 2019Mar 22, 2019$868,741of $1.0M target18$48,263DebtRule 506(b)Form D ↗
Sep 6, 2017Sep 21, 2017$3,500,000fully sold1$3.5MEquityRule 506(b)Form D ↗
Oct 21, 2015Nov 4, 2015amended Mar 14, 2017$3,234,867of $3.5M target25$129KEquityRule 506(b)Form D/A ↗1 earlier filing
Total, six offerings$16,358,881

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Perfusio's Form D filed Dec 10, 2024.

GM
RB
Richard Balot
Executive officer and director
JA
Joffre Alvarez
Executive officer
WH

Earlier filings also listed Thomas Ferguson (director, last listed Jan 2023), Steve Taylor (director, last listed Jan 2023), Peter Geiger (executive officer, last listed Jan 2023), Kenichi Matsumura (director, last listed Jan 2023), David Lavance (director, last listed Jan 2023), Cheng Chen (executive officer, last listed Jan 2023), Monte Tucker (executive officer and director, last listed Sep 2021) and Mike Snow (director, last listed Sep 2021).

Sources

  1. SECPERFUSIO CORP. Form D, filed Aug 19, 2020
  2. SECPERFUSIO CORP. Form D, filed Nov 4, 2015
  3. SECPERFUSIO CORP. filing history